Bibliografisk note

Funding Information:
Drs. Meyhoff and Aasvang are members of the WARD Project management committee, a research project investigating wireless monitoring. The WARD Project is funded by Innovation Fund Denmark (Copenhagen, Denmark), Novo Nordic Foundation (Copenhagen, Denmark), Danish Cancer Society (Copenhagen, Denmark), Radiometer Medical (Copenhagen, Denmark), Copenhagen Center for Health Technology (Copenhagen,Denmark),Isansys Ltd (Oxfordshire, United Kingdom), and AP Møller Foundation (Copenhagen, Denmark). Dr. Meyhoff also reports direct and indirect research funding from Ferring Pharmaceuticals (Copenhagen, Denmark), Merck, Sharp & Dohme Corp. (New Jersey), and Boehringer Ingelheim (Ingelheim am Rhein, Germany) outside the submitted work as well as lecture fees from Radiometer. Dr. Aasvang also reports institutional research funding from Norpharma A/S (Copenhagen, Denmark) outside the submitted work as well as lecture fees from Radiometer. The other authors declare no competing interests.